卓正医疗二战港股：盈利状况改善，腾讯、天图投资等参投

网易新闻2025-05-20

近日，卓正医疗向港交所递交上市申请，海通国际、浦银国际担任联席保荐人。2024年5月，卓正医疗曾首次向港交所递交上市申请，最终失效。卓正医疗成立于2012年，收入主要来自提供医疗服务，主要包括实体医疗服务和在线医疗服务，涵盖儿科、齿科、眼科、皮肤科、耳鼻喉及外科、妇科及内科等一系列专科。目前，卓正医疗在中国各地拥有及经营20家医疗服务机构，包括18家诊所和两家医院，覆盖深圳、广州、北京、成都、苏州...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2536667994?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2025-05-20 14:17","share_image_url":"https://static.laohu8.com/b0d1b7e8843deea78cc308b15114de44","id":"2536667994","market":"sh","top_or_hot":-1,"title":"卓正医疗二战港股：盈利状况改善，腾讯、天图投资等参投","media":"网易新闻","content":"<div>\n<p>近日，卓正医疗向港交所递交上市申请，海通国际、浦银国际担任联席保荐人。2024年5月，卓正医疗曾首次向港交所递交上市申请，最终失效。卓正医疗成立于2012年，收入主要来自提供医疗服务，主要包括实体医疗服务和在线医疗服务，涵盖儿科、齿科、眼科、皮肤科、耳鼻喉及外科、妇科及内科等一系列专科。目前，卓正医疗在中国各地拥有及经营20家医疗服务机构，包括18家诊所和两家医院，覆盖深圳、广州、北京、成都、苏州...</p>\n\n<a href=\"https://finance.sina.com.cn/roll/2025-05-20/doc-inexetxe1449743.shtml\">网页链接</a>\n\n</div>\n","source":"sina","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>卓正医疗二战港股：盈利状况改善，腾讯、天图投资等参投</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n卓正医疗二战港股：盈利状况改善，腾讯、天图投资等参投\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-05-20 14:17 北京时间&nbsp;&nbsp;&nbsp;<a href=https://finance.sina.com.cn/roll/2025-05-20/doc-inexetxe1449743.shtml><strong>网易新闻</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>近日，卓正医疗向港交所递交上市申请，海通国际、浦银国际担任联席保荐人。2024年5月，卓正医疗曾首次向港交所递交上市申请，最终失效。卓正医疗成立于2012年，收入主要来自提供医疗服务，主要包括实体医疗服务和在线医疗服务，涵盖儿科、齿科、眼科、皮肤科、耳鼻喉及外科、妇科及内科等一系列专科。目前，卓正医疗在中国各地拥有及经营20家医疗服务机构，包括18家诊所和两家医院，覆盖深圳、广州、北京、成都、苏州...</p>\n\n<a href=\"https://finance.sina.com.cn/roll/2025-05-20/doc-inexetxe1449743.shtml\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"HSCEI","symbol_name":"国企指数","start_time":0,"source_url":"https://finance.sina.com.cn/roll/2025-05-20/doc-inexetxe1449743.shtml","article_id":"2536667994","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2536667994","pubTimestamp":1747721820,"columns":[],"sourceInfo":{"source_id":"sina","name":"sina"},"weMediaInfo":null,"summary":"近日，卓正医疗向港交所递交上市申请，海通国际、浦银国际担任联席保荐人。2024年扭亏，盈利状况改善2022年至2024年，卓正医疗实现收入分别为4.73亿元、6.90亿元、9.59亿元，呈逐年上升趋势。获知名机构投资2014年以来，卓正医疗先后进行5轮融资，获得腾讯、天图投资等多家知名机构投资，估值从1560万美元增加至5.1亿美元。此次港股IPO，卓正医疗募集资金主要用于以下方面。","collect":0,"end_time":0,"defaultTopTitle":"sina.com.cn","property":[],"viewcount":null,"language":"zh","relate_stocks":{"159891":"医疗","HSCEI":"国企指数","LU0531970944.HKD":"HSBC GIF BRIC EQUITY \"AC\" (HKD) ACC","LU0269904917.USD":"SCHRODER ISF GLOBAL EMERGING MARKET OPPORTUNITIES \"A\" (USD) ACC","LU0501845795.SGD":"瑞银大中华区股票基金P Acc SGD","LU0541502299.USD":"ALLSPRING  EMERGING MARKETS EQUITY \"I\" (USD) ACC","LU1993786604.SGD":"UBS (LUX) EQUITY SICAV ALL CHINA \"P\" (SGD) ACC","HSTECH":"恒生科技指数","HTCD.SI":"Tencent HK SDR 10to1","LU0127658192.USD":"EASTSPRING INVESTMENTS GLOBAL TECHNOLOGY \"A\" (USD) ACC","YANG":"三倍做空富时中国ETF-Direxion","LU0588545904.SGD":"Eastspring Investments - Asian Equity Income ASDM SGD","07226":"南方两倍做多恒科","LU0314109678.HKD":"MANULIFE GF DRAGON GROWTH \"AA\" (HKD) INC","LU1251922891.USD":"NINETY ONE GSF ALL CHINA EQUITY \"A\" (USD) ACC","LU1282649141.HKD":"ALLIANZ ASIAN MULTI INCOME PLUS \"AMG\" (HKD) INC","IE0034224299.USD":"PINEBRIDGE ASIA EX JAPAN EQUITY \"A\" (USD) ACC","LU0072462343.USD":"贝莱德亚洲巨龙基金","LU1688375341.USD":"贝莱德中国灵活股票基金","LU1282651048.USD":"ALLIANZ GEM EQUITY HIGH DIVIDEND \"AMG\" (USD) INC","LU0898667661.SGD":"JPMorgan Funds - Asia Pacific Income A (mth) SGD-H","LU0650527681.SGD":"Fidelity China Consumer A-SGD","LU1481107354.HKD":"HSBC GIF HONG KONG EQUITY \"AD\" (HKD) INC","LU0634319403.HKD":"ALLIANZ HONG KONG EQUITY \"AT\" (HKD) ACC","LU0456827905.SGD":"JPMorgan Funds - China A (acc) SGD","LU0823426308.USD":"法巴中国股票基金","LU1831875114.USD":"SCHRODER ISF ALL CHINA EQUITY \"A\" (USD) ACC","SG9999018865.SGD":"United Global Quality Growth Fd Cl Dist SGD-H","LU0572939691.SGD":"Janus Henderson Horizon Asian Dividend Income A2 SGD","LU0516423091.SGD":"FULLERTON LUX FUNDS - ASIA FOCUS EQUITIES \"I\" (SGD) ACC","LU1211504680.USD":"ALLIANZ HIGH DIVIDEND ASIA PACIFIC EQUITY \"AM\" (USD) INC","LU0348825331.USD":"ALLIANZ CHINA EQUITY \"A\" (USD) INC","LU0531971595.HKD":"HSBC GIF CHINESE EQUITY \"AD\" (HKD) INC","01973":"天图投资","LU0791591158.USD":"ALLSPRING  EMERGING MARKTES EQUITY INCOME \"I\" (USD) ACC","LU0384037296.USD":"ALLIANZ ASIAN MULTI INCOME PLUS \"AT\" (USD) ACC","IE00B0JY6N72.USD":"PINEBRIDGE GLOBAL EMERGING MARKETS FOCUS EQUITY \"A\" (USD) ACC","LU0084288322.USD":"Natixis Asia Equity RD USD","LU1226288253.USD":"UBS (LUX) KEY SELECTION SICAV - CHINA ALLOCATION  OPPORTUNITY (USD) \"P\" (USD) INC","LU0611395673.USD":"NINETY ONE GSF EMERGING MARKETS EQUITY \"A\" (USD) ACC","LU0106959298.USD":"UBS (LUX) EQUITY FUND - EMERGING MARKETS SUSTAINABLE LEADERS (USD) \"P\" (USD) ACC","LU1048484197.HKD":"ALLIANZ CHINA MULTI INCOME PLUS \"AT\" (HKD) ACC","LU0143863784.USD":"CT (LUX) I GLOBAL EMERGING MARKET EQUITIES\"DU\" (USD) ACC","LU1675838814.USD":"AB SICAV I - EMERGING MARKETS LOW VOLATILITY EQUITY PORTFOLIO \"AD\" (USD) INC","SG9999018857.SGD":"United Global Quality Growth Fd Cl Acc SGD-H","LU1046422090.SGD":"Fidelity Pacific A-SGD","LU1224444064.USD":"ALLIANZ GEM EQUITY HIGH DIVIDEND \"AM\" (USDHDG) INC"},"translate_title":"Zhuozheng Medical World War II Hong Kong stocks: profitability improves, Tencent, Tiantu Investment and others participate in the investment","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"159891":1,"HSTECH":1,"07226":1,"HTCD.SI":0.6,"01973":1,"HSCEI":1,"YANG":1,"TCHmain":0.6},"content_text":"近日，卓正医疗向港交所递交上市申请，海通国际、浦银国际担任联席保荐人。2024年5月，卓正医疗曾首次向港交所递交上市申请，最终失效。卓正医疗成立于2012年，收入主要来自提供医疗服务，主要包括实体医疗服务和在线医疗服务，涵盖儿科、齿科、眼科、皮肤科、耳鼻喉及外科、妇科及内科等一系列专科。目前，卓正医疗在中国各地拥有及经营20家医疗服务机构，包括18家诊所和两家医院，覆盖深圳、广州、北京、成都、苏州、长沙、上海、重庆、杭州及武汉。此外，公司在新加坡经营3家全科诊所。2024年扭亏，盈利状况改善2022年至2024年，卓正医疗实现收入分别为4.73亿元、6.90亿元、9.59亿元，呈逐年上升趋势。2022年、2023年，公司年内亏损分别为2.22亿元、3.53亿元。2024年，公司实现年内利润8022.7万元，成功扭亏为盈。期间，公司经调整净利润分别为-1.23亿元、-0.44亿元和0.11亿元。2022年至2024年，公司各期毛利率分别为9.3%、19.3%、23.6%，逐步提升。公司称，这得益于公司经营效率提高及就诊人次的增加，规模经济效益开始显现。获知名机构投资2014年以来，卓正医疗先后进行5轮融资，获得腾讯、天图投资等多家知名机构投资，估值从1560万美元增加至5.1亿美元。截至递表前，创始人王志远为卓正医疗最终单一最大股东，通过直接及间接方式合计控制公司26.48%的投票权。此次港股IPO，卓正医疗募集资金主要用于以下方面。其一，用于通过打造一个医疗人工智能应用的专业人才库、与领先的科研机构及公司开展战略合作及外部采购，同时内部信息及数据技术部门对公司自身的信息技术系统进行改进，部署人工智能前沿技术来革新医疗服务及提高运营效率。其二，用于升级现有医疗服务机构及设立新的医疗服务机构。其三，用于在适当机会出现时收购一线城市及新一线城市中业绩良好的医疗服务机构。其四，用作营运资金及其他一般公司用途。（文章序列号：1924674178125008896/PLH）\n\n\n海量资讯、精准解读，尽在新浪财经APP","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"shareholding","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2536667994","isCrawlerRequest":true}